Blood Pressure and Glaucoma | Driving with Dr. David Richardson Ep 02
Hello, I’m Dr. David Richardson. I’m an Ophthalmologist in Southern California and my practice is primarily glaucoma and cataract treatment. So my first video began discussing holistic approach to glaucoma treatment taking into account things other than...Physical Activity and Rate of Visual Field Loss
A study to be published in the journal, “Ophthalmology” looked at the association between level of physical activity in patients with glaucoma and rate of visual field loss.[1] This study is what would be called a longitudinal observational study which essentially...Holistic Approach to Glaucoma | Driving with Dr. David Richardson Ep 01
Hi! My name is David Richardson. I’m an eye surgeon that specializes in cataract and glaucoma surgery. The first video here is going to be on what I would call a holistic approach to glaucoma. Now, by holistic I don’t mean woowoo. I’m very much based...Trabeculotomy or Goniotomy – Just Defer It
Why Defer Trabeculotomy or Goniotomy Recently there has been a large increase in the number of cataract and glaucoma surgeons who are performing a type of minimally invasive glaucoma surgery that goes by various names, all of which have the term “goniotomy” or...Does the CyPass Glaucoma Implant Damage the Eye?
What is the CyPass Stent? The CyPass is a small tube-shaped device that has for the last few years been implanted in patients with glaucoma. This was done at the time of cataract surgery in order to shunt fluid from the front of the eye into a space where it can then...FDA Approves Preservative-Free Xelpros™ for Open-Angle Glaucoma
FDA Approves preservative-free XELPROS™ (latanoprost ophthalmic emulsion 0.005%) for intraocular pressure (IOP) reduction in patients with open-angle glaucoma and ocular hypertension
PolyActiva Commences Clinical Trial of Biodegradable Ocular Implant for Glaucoma
Clinical Trial Begins For PolyActiva Biodegradable Glaucoma Implant. PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently received USD$12million in venture capital to fund its Phase 1 Clinical Trial which will evaluate the safety and tolerability of its PA5108 ocular implant designed to biodegrade after the treatment period.
MicroInvasive Glaucoma Surgery (MIGS) Where To Next?
Iqbal Ike K. Ahmed, MD, FRCSC, asks surgeons to comment on what excites them about the future of minimally invasive glaucoma surgery (MIGS). Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; and David Richardson, MD, discuss MIGS devices in the pipeline and explain how these procedures improve the quality of life for both patients and physicians.
Ab Interno Canaloplasty (ABiC™) In The Spotlight
Iqbal Ike K. Ahmed, MD, FRCSC, asks a group of experts featuring Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and I. Paul Singh, MD, to address the misconceptions and barriers to adoption for ab interno canaloplasty (ABiC). The group explains how ABiC iTrack (Ellex) compares to other minimally invasive glaucoma surgery (MIGS) procedures.